World's Best Scientists 2026 revealed!

Overview

Marco Montagna is affiliated with the Istituto Oncologico Veneto in Italy. Their research primarily focuses on the genetic and molecular biology aspects of cancer, with a specific emphasis on BRCA gene mutations and their implications in cancer risk and pathology.

Montagna's main fields of study include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Their work extends into subfields such as:

  • Genetics
  • Surgery
  • Molecular Biology
  • Oncology
  • Public Health, Environmental and Occupational Health

Key topics covered in Montagna's research include:

  • BRCA gene mutations in cancer
  • DNA Repair Mechanisms
  • Male Breast Health Studies
  • Ovarian cancer diagnosis and treatment
  • Genetic factors in colorectal cancer
  • CRISPR and Genetic Engineering
  • Genetic Associations and Epidemiology

Recent papers authored or co-authored by Montagna are:

  • Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants, 2020, JAMA Oncology
  • Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores, 2021, JNCI Journal of the National Cancer Institute
  • Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants, 2021, Genetics in Medicine
  • Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2, 2023, British Journal of Cancer
  • Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study, 2023, European Journal of Cancer

The publication venues where Montagna frequently contributes are:

  • Genetics in Medicine
  • JAMA Oncology
  • JNCI Journal of the National Cancer Institute
  • British Journal of Cancer
  • European Journal of Cancer

Frequent co-authors of Marco Montagna include:

  • Siranoush Manoukian
  • Paolo Radice
  • Irene L. Andrulis
  • Maria A. Caligo
  • Miguel de la Hoya

Best Publications

  • Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

    Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek

  • Association Between BRCA1 and BRCA2 Mutations and Survival in Women with Invasive Epithelial Ovarian Cancer

    Kelly L. Bolton;Kelly L. Bolton;Georgia Chenevix-Trench;Cindy Goh;Siegal Sadetzki

  • Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

    Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley

  • Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

    Timothy R. Rebbeck;Nandita Mitra;Fei Wan;Olga M. Sinilnikova

  • Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    Catherine M Phelan;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Jonathan P Tyrer;Siddhartha P Kar

  • A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

    Antonis C. Antoniou;Xianshu Wang;Zachary S. Fredericksen;Lesley McGuffog

  • Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

    Roger L Milne;Roger L Milne;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Kyriaki Michailidou;Kyriaki Michailidou;Jonathan Beesley

  • Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

    Haoyu Zhang;Haoyu Zhang;Thomas U. Ahearn;Julie Lecarpentier;Daniel Barnes

  • Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

    Fergus J. Couch;Xianshu Wang;Lesley McGuffog;Andrew Lee

  • Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors.

    Marco Ripa;Laura Galli;Andrea Poli;Chiara Oltolini

  • Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers

    Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Lesley McGuffog;Daniel Barrowdale;Andrew Lee

  • Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

    Timothy R. Rebbeck;Tara M. Friebel;Eitan Friedman;Ute Hamann

  • Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families

    Marco Montagna;Maurizia Dalla Palma;Chiara Menin;Simona Agata

  • Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

    Antonis C. Antoniou;Jonathan Beesley;Lesley McGuffog;Olga M. Sinilnikova

  • Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer

    Francisco J. Candido-dos-Reis;Honglin Song;Ellen L. Goode;Julie M. Cunningham

  • Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores

    Julie Lecarpentier;Valentina Silvestri;Karoline B. Kuchenbaecker;Karoline B. Kuchenbaecker;Daniel Barrowdale

  • Association Between MDM2–SNP309 and Age at Colorectal Cancer Diagnosis According to p53 Mutation Status

    Chiara Menin;Maria Chiara Scaini;Gian Luca De Salvo;Martina Biscuola

  • The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers

    H Aberle;C Bierkamp;D Torchard;O Serova

  • Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170

    Alison M. Dunning;Kyriaki Michailidou;Karoline B. Kuchenbaecker;Deborah Thompson

  • Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

    Mia M. Gaudet;Tomas Kirchhoff;Todd Green;Joseph Vijai

Frequent Co-Authors

Irene L. Andrulis
Irene L. Andrulis University of Toronto
Georgia Chenevix-Trench
Georgia Chenevix-Trench QIMR Berghofer Medical Research Institute
Fergus J. Couch
Fergus J. Couch Mayo Clinic
Melissa C. Southey
Melissa C. Southey Monash University
Katherine L. Nathanson
Katherine L. Nathanson University of Pennsylvania
Susan L. Neuhausen
Susan L. Neuhausen City Of Hope National Medical Center
Javier Benitez
Javier Benitez Instituto de Salud Carlos III
Lesley McGuffog
Lesley McGuffog University of Cambridge
Heli Nevanlinna
Heli Nevanlinna University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens doors to a wide range of rewarding online degree programs and health-related career paths. For those passionate about nutrition, pursuing one of the best online registered dietitian programs can be an excellent step toward becoming a licensed dietitian. These programs provide flexibility and can often be completed at a lower cost.

For current nurses, an rn to bsn online program offers a convenient way to advance clinical skills and career opportunities. If you’re interested in healthcare leadership, consider an online masters in healthcare management. This qualification is highly regarded for roles in administration and policy.

There is also growing demand for mental health professionals. Completing one of the psychiatric mental health nurse practitioner programs online equips graduates to support communities facing mental health challenges. These accessible online pathways help you build on your Biology or Biochemistry background and expand your impact in the healthcare sector.

Best Scientists Citing Marco Montagna

Trending Scientists

Recently Published Articles